Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV001221072 | SCV001393095 | pathogenic | not provided | 2024-01-24 | criteria provided, single submitter | clinical testing | This sequence change creates a premature translational stop signal (p.Ala273Glyfs*38) in the SLC12A3 gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in SLC12A3 are known to be pathogenic (PMID: 20848653, 22009145, 25841442). This variant is not present in population databases (gnomAD no frequency). This premature translational stop signal has been observed in individuals with Gitelman syndrome (PMID: 19668106, 30596175). ClinVar contains an entry for this variant (Variation ID: 949583). For these reasons, this variant has been classified as Pathogenic. |
Natera, |
RCV001828761 | SCV002089336 | pathogenic | Familial hypokalemia-hypomagnesemia | 2020-10-14 | no assertion criteria provided | clinical testing |